SynthesisEuropean journal of neurology2026
Trans-Synaptic Retrograde Retinal Degeneration After Post-Chiasmatic Stroke: A Systematic Review of Empirical Evidence.
Synthesis in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Visual impairment in multiple sclerosis involving post-geniculate gray and white matter: above and beyond.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRetrograde trans-synaptic degeneration (RTSD) refers to the progressive loss of retinal cells following damage to the post-geniculate visual pathway. The advent of optical coherence tomography (OCT) has allowed the measurement and quantification of retinal layers, in turn providing compelling evidence of RTSD in stroke patients and highlighting that assessing the temporal and functional evolution of RTSD has important clinical implications.
methodsWe conducted a systematic review up until 7th July 2025 to summarize the OCT evidence on post-stroke RTSD. Eligible articles on this topic were searched in PubMed, Web of Science, and Scopus databases. Twenty-eight papers, involving 888 patients and 624 healthy controls, were included, and their results were systematically described and qualitatively analyzed.
resultsOverall, literature shows that RTSD is a frequent outcome of post-chiasmatic strokes. RTSD is operationalized by measuring the thickness of the peripapillary retinal nerve fiber and macular layers. The latter appears to be a more robust structural biomarker, showing more consistent findings across studies, with its magnitude better correlating with patients' visual field defects. RTSD starts early after the stroke's onset and progresses for several years, with severity depending on lesion location and extension. Future investigations are needed to draw more robust conclusions on RTSD temporal dynamics, clarifying the relation between structural and functional loss.
conclusionsCurrent literature highlights the need to consider the RTSD among the primary outcomes of post-chiasmatic stroke, given its implications on clinical management and neurorehabilitation, making the longitudinal assessment of this degenerative process crucial for prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.